Finance Home - My Yahoo - Yahoo! - Help

Monday, December 28, 2009, 6:10PM ET - U.S. Markets Closed. Dow  0.26% Nasdaq  0.24%

RXi Pharmaceuticals Corporation (RXII)

At 3:59PM ET: 4.31   0.31 (6.71%)

MORE ON RXII

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Industry: Biotechnology Get Industry for:
RXII SECTOR / INDUSTRY MEMBERSHIP Sector: Healthcare Industry: Biotechnology INTRADAY PERFORMANCE SUMMARY Name Ticker Change RXi Pharmaceuticals Corporation RXII 6.71% Biotechnology ^YHOh788 0.61% View Biotechnology Industry Center BIOTECHNOLOGY INDUSTRY NEWS • Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing Mon 3:25 PM - Business Wire • Revance Therapeutics raises $25 million Mon 3:05 PM - at bizjournals.com • Sunesis registers for stock sale of up to $50M Mon 3:05 PM - at bizjournals.com • 4-Star Stocks on the Upswing Mon 2:50 PM - at Motley Fool • Cell Therapeutics tries to deter ‘coercive takeover’ Mon 1:05 PM - at bizjournals.com More Industry News... TOP BIOTECHNOLOGY COMPANIES BY MARKET CAP Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 57.66 0.42% 58.36B 12.58 Gilead Sciences Inc. GILD 43.26 0.60% 38.93B 16.73 Celgene Corporation CELG 56.74 0.64% 26.08B 70.75 Biogen Idec Inc. BIIB 53.27 1.97% 15.41B 17.83 Genzyme Corp. GENZ 49.61 2.29% 13.17B 28.28 RXi Pharmaceuticals Corporation RXII 4.31 6.71% 69.85M N/A Showing 1 - 5 of 200 - View All More Top Companies: by Performance, by Valuation, by Growth, more... RXII VS. INDUSTRY LEADERS Statistic Industry Leader RXII RXII Rank Market Capitalization AMGN 58.36B 69.85M 120 / 200 P/E Ratio (ttm) BMRN 101.45 N/A N/A PEG Ratio (ttm, 5 yr expected) HGSI 153.85 N/A N/A Revenue Growth (Qtrly YoY) OSIR 963.70% N/A N/A EPS Growth (Qtrly YoY) SSRX 1349.60% N/A N/A Long-Term Growth Rate (5 yr) AMLN 62% N/A N/A Return on Equity (ttm) INSM 184.07% -181.16% 115 / 200 Long-Term Debt/Equity (mrq) N/A Dividend Yield (annual) PDLI 14.40% N/A N/A View Leaders & Laggards MORE ON BIOTECHNOLOGY • Industry Summary • News • Leaders & Laggards • Company List • Industry Calendar RELATED INDUSTRIES • Diagnostic Substances • Drug Delivery • Drug Manufacturers - Major • Drug Manufacturers - Other • Drug Related Products • Drugs - Generic Top Performing Industries | Complete Industry List
Add to Portfolio     Set Alert     Email to a Friend Get Industry for Another Symbol: Symbol Lookup • Research Reports Screener • Industry Center